Cohort study reveals risk factors for early metachronous distant metastasis in oral squamous cell carcinoma, indicating the value of risk-adapted cancer surveillance.
Objectives Distant metastases (DMs) are a significant prognostic factor in oral squamous cell carcinoma (OSCC). This study analyzed the pattern and predictors of metachronous DMs (MDMs) over time in a large OSCC cohort treated with curative intent. Materials and methods A total of 1,122 patients with primary OSCC were treated at the University Medical Center Hamburg-Eppendorf between 2009 and 2019. After excluding patients with synchronous metastases or palliative treatment, 1,040 patients remained for analysis. Results Of these, 93 patients (8.94%) developed MDMs. The lungs were the most frequent site ( n = 64), followed by bone ( n = 26), thoracic lymph nodes ( n = 19), and liver ( n = 17). The estimated mean time to MDM was approximately 430 days. In patients with late-onset metastasis (≥ 24 months), the lung was most often the sole site involved. Multiple metastatic sites were observed in 40.86% of cases. Cox regression analysis identified several independent factors associated with early metachronous dissemination (≤ 12 months after diagnosis): pN2c nodal status (HR 10.778, 95% CI 1.123–103.405, p = 0.039), age < 60 years (HR 3.626, 95% CI 1.048–12.547, p = 0.042), and treatment with surgery plus adjuvant radiochemotherapy (HR 20.025, 95% CI 1.954–205.232, p = 0.012). Conclusion The occurrence of MDMs was observed in around 10% of OSCC patients. Early metachronous dissemination was associated with pN2c, age < 60 years and combination therapy. Clinical Relevance These findings support a time- and pattern-dependent model of distant dissemination in OSCC and may inform risk-adapted surveillance and treatment strategies.
No takes yet. Share an insight, caveat, or question.
Roehl et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: